GIOSTAR has played a pivotal role in regenerative medicine in India for many years. This trend continues with the launch of a new stem cell / cancer research and therapy center in Chandigarh, one of the country’s most prestigious cities.
GIOSTAR Chicago reviews in greater detail the potential for mesenchymal stem cells (MSCs) to reduce inflammation. This may provide benefit to patients suffering from multiple sclerosis, rheumatoid arthritis, and other autoimmune disorders.
Beyond groundbreaking therapies backed by decades of research, GIOSTAR is a world leader in medical tourism. Learn more about the newest center opening, in the beautiful Cancun Riviera, Mexico.